Zevra Therapeutics, Inc.
ZVRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $34 | $43 | $65 | $112 |
| Short-Term Investments | $36 | $25 | $17 | $0 |
| Receivables | $11 | $17 | $8 | $2 |
| Inventory | $2 | $24 | $0 | $0 |
| Other Curr. Assets | $3 | -$23 | $1 | $0 |
| Total Curr. Assets | $86 | $87 | $93 | $115 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $2 |
| Goodwill | $5 | $5 | $0 | $0 |
| Intangibles | $69 | $69 | $0 | $0 |
| Long-Term Investments | $6 | $0 | $20 | $15 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $11 | $10 | $1 | $0 |
| Total NC Assets | $92 | $85 | $23 | $18 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $178 | $172 | $115 | $133 |
| Liabilities | – | – | – | – |
| Payables | $13 | $14 | $4 | $1 |
| Short-Term Debt | $0 | $38 | $5 | $0 |
| Tax Payable | $14 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $11 | $1 | $1 |
| Total Curr. Liab. | $34 | $74 | $12 | $4 |
| LT Debt | $60 | $5 | $13 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $45 | $31 | $15 | $0 |
| Total NC Liab. | $104 | $37 | $28 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $2 |
| Total Liabilities | $138 | $110 | $40 | $6 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$505 | -$400 | -$354 | -$267 |
| AOCI | $1 | -$0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $40 | $62 | $75 | $127 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $178 | $172 | $115 | $133 |
| Net Debt | $26 | -$0 | -$48 | -$112 |